Sharon S. Challberg, Ph.D
Co-Founder and COO
Dr. Challberg brings a deep background in the life science industry, having served in multiple roles including product development, transfer and commercialization, regulatory affairs and business development in both large company and entrepreneurial settings. As Director of R&D at Life Technologies, Dr. Challberg led the team that developed ViraPap, the first molecular diagnostic test to receive FDA clearance. In her role as Vice President of R&D at Digene Corporation, she led the development of the next generation Hybrid Capture technology that formed the foundation for the Company's growth engine in molecular diagnostics for multiple infectious disease targets. Dr. Challberg subsequently founded and served as CEO of Marligen Biosciences and General Manager of ATCC Cell Systems prior to joining Propagenix.